Jounce will not be eligible for the remaining contingent payments of up to $645 million in milestones or royalties based upon worldwide sales under the original license agreement.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,